NDC 31722-005-32 - Mesalamine

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 31722-005
Requested NDC: 31722-005-32
Package NDCs from labels: 31722-005-32, 31722-005-30, 31722-005-31
Manufacturer: Camber Pharmaceuticals, Inc. | Annora Pharma Private Limited
Effective date: 2024-02-26
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
Mesalamine - Camber Pharmaceuticals, Inc. \| Annora Pharma Private Limited	Camber Pharmaceuticals, Inc. \| Annora Pharma Private Limited	2024-02-26	HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
31722-005-30	Mesalamine	5 in 1 CARTON	SUPPOSITORY	5	4
31722-005-31	Mesalamine	7 in 1 CARTON	SUPPOSITORY	7	4
31722-005-32	Mesalamine	6 in 1 PACKAGE	SUPPOSITORY	6	4

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
31722-005	MESALAMINE (MESALAMINE) SUPPOSITORY [CAMBER PHARMACEUTICALS, INC.]	4	Current NDC, Legacy NDC, 3 package rows	20240228_efa9d039-ae1f-4cd6-98f2-e87a901dfaeb.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
31722-005-30	EA - Each	31722-005	280c6a2e-f10e-44c7-acb8-89fcda18781e	1	2020-09-14
31722-005-32	EA - Each	31722-005	d00e030e-2fbc-477d-9788-c29745075145	1	2020-09-14

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 3 of 3 · 59 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Mesalamine	MESALAMINE	Bryant Ranch Prepack	06792d20-d7e9-4b66-a4cb-cd0cf1a2db25	2024-06-28	Warnings, Adverse reactions	Exact identifier rxcui: 248420 unii: 4Q81I59GXC
Mesalamine	MESALAMINE	Rising Pharma Holdings, Inc.	de981df1-747a-480d-a866-e72332a1544d	2024-06-14	Warnings, Adverse reactions	Exact identifier rxcui: 248420 unii: 4Q81I59GXC
MESALAMINE	MESALAMINE	Bryant Ranch Prepack	063ca661-1b5c-4941-a5b9-5dd0fa46b3d0	2024-05-29	Warnings, Adverse reactions	Exact identifier unii: 4Q81I59GXC
Mesalamine	MESALAMINE	Amneal Pharmaceuticals LLC	00f77203-3615-47e8-ae25-6e1cf8a2a00a	2024-05-23	Warnings, Adverse reactions	Exact identifier unii: 4Q81I59GXC
Mesalamine	MESALAMINE	Bryant Ranch Prepack	c9b1ef9d-1d06-48e7-87d2-7985b99124a6	2024-05-01	Warnings, Adverse reactions	Exact identifier unii: 4Q81I59GXC
mesalamine	MESALAMINE	Golden State Medical Supply, Inc.	170657d1-1f32-f036-e063-6294a90a4ed4	2024-04-26	Warnings, Adverse reactions	Exact identifier unii: 4Q81I59GXC
MESALAMINE	MESALAMINE	Lannett Company Inc.	29dbe417-15a9-4c4d-846b-81cabda7ac70	2024-02-29	Warnings, Adverse reactions	Exact identifier unii: 4Q81I59GXC
Mesalamine	MESALAMINE	Camber Pharmaceuticals, Inc.	efa9d039-ae1f-4cd6-98f2-e87a901dfaeb	2024-02-26	Warnings, Adverse reactions	Exact identifier application number: ANDA213377 ndc (package): 31722-005-32 ndc (package): 31722-005-30 ndc (package): 31722-005-31 ndc (product): 31722-005 ndc11 (package): 31722000532 rxcui: 248420 spl id: 1248c2d3-b241-5551-e063-6294a90a2f4e spl set id: efa9d039-ae1f-4cd6-98f2-e87a901dfaeb unii: 4Q81I59GXC
Mesalamine	MESALAMINE	Camber Pharmaceuticals, Inc.	04ce2182-2e8c-4598-a269-550cfaddde6c	2024-02-15	Warnings, Adverse reactions	Exact identifier unii: 4Q81I59GXC
Mesalamine	MESALAMINE	ANI Pharmaceuticals, Inc.	3cf751f2-a0c9-45d7-8acb-2bc61db0e4ac	2024-02-14	Warnings, Adverse reactions	Exact identifier unii: 4Q81I59GXC
Mesalamine	MESALAMINE	Aurobindo Pharma Limited	d6c0fc76-644e-4301-9672-f432061e3d37	2024-01-20	Warnings, Adverse reactions	Exact identifier unii: 4Q81I59GXC
MESALAMINE	MESALAMINE	Alembic Pharmaceuticals Inc.	87d3d62d-2dc3-4e6f-be33-cabbca12e8f7	2024-01-09	Warnings, Adverse reactions	Exact identifier unii: 4Q81I59GXC
mesalamine	MESALAMINE	Teva Pharmaceuticals USA, Inc.	8d27a608-3ba1-4799-be38-c00fb08ce3ce	2023-12-19	Warnings, Adverse reactions	Exact identifier unii: 4Q81I59GXC
Mesalamine Rectal	MESALAMINE	Amring Pharmaceuticals Inc.	87de237c-febb-42ca-b2a4-b444396f8640	2023-12-15	Warnings, Adverse reactions	Exact identifier rxcui: 248420 unii: 4Q81I59GXC
Mesalamine	MESALAMINE	Sun Pharmaceutical Industries, Inc.	fd8b02de-7dfa-444d-a1f8-1436b578e0cb	2023-12-01	Warnings, Adverse reactions	Exact identifier unii: 4Q81I59GXC
Mesalamine	MESALAMINE	Mylan Pharmaceuticals Inc.	c8b93ea3-0367-4605-b87f-06c3812ff3b7	2023-11-30	Warnings, Adverse reactions	Exact identifier unii: 4Q81I59GXC
Mesalamine	MESALAMINE	Zydus Pharmaceuticals USA Inc.	cd8493f7-91fd-4c2d-b3d7-c1301825586b	2023-10-26	Warnings, Adverse reactions	Exact identifier unii: 4Q81I59GXC
mesalamine	MESALAMINE	Zydus Pharmaceuticals USA Inc.	533bfaf5-0add-4b49-a4f2-ddea2b83f65d	2023-10-26	Warnings, Adverse reactions	Exact identifier unii: 4Q81I59GXC
MESALAMINE	MESALAMINE	Alembic Pharmaceuticals Limited	4ef59b85-e5a5-479f-a1fe-e1cee4d87670	2022-11-07	Warnings, Adverse reactions	Exact identifier unii: 4Q81I59GXC

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.